Skip to main content
. 2023 Oct 24;2023(10):CD013584. doi: 10.1002/14651858.CD013584.pub2

Inui 1999.

Study characteristics
Methods Randomised controlled trial
Run‐in period: not specified. Received November 1998; revised February 1999. Published 1999
Number of study centres and location: not specified
Participants Twenty‐four participants were assessed in this study.
Inclusion criteria: adult patients undergoing cardiac surgery
Interventions Intervention: Duraflo II heparin‐coated CPB circuits
Control: uncoated circuit
Outcomes TNF‐α, IL‐6, IL‐8, MPO, TAT, PIC, TM
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Twenty‐four patients were randomly assigned to be investigated. Nine participants underwent CABG, and 15 underwent valve replacement or valve repair surgery.
Allocation concealment (selection bias) Unclear risk No details given
Blinding of participants and personnel (performance bias)
All outcomes Unclear risk No details given
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk No details given
Incomplete outcome data (attrition bias)
All outcomes Low risk All data included in analysis
Selective reporting (reporting bias) Low risk No reporting bias apparent
Other bias Unclear risk No details given